Surgery: light – thermal – and electrical application – Light – thermal – and electrical application – Electrical therapeutic systems
Reexamination Certificate
2007-05-29
2007-05-29
Pezzuto, Robert (Department: 3766)
Surgery: light, thermal, and electrical application
Light, thermal, and electrical application
Electrical therapeutic systems
C607S005000, C607S009000
Reexamination Certificate
active
10856107
ABSTRACT:
Exemplary methods for increasing efficiency and/or increasing success of terminating ventricular tachyarrhythmia. An exemplary method includes stimulation of a parasympathetic nerve before, during and/or after delivery of antitachycardia pacing pulses, a cardioversion stimulus and/or a defibrillation stimulus. Various exemplary methods include delivering one or more stimulation pulses during postinspiration. Other methods and/or devices are also disclosed.
REFERENCES:
patent: 4712555 (1987-12-01), Thornander et al.
patent: 4788980 (1988-12-01), Mann et al.
patent: 4940052 (1990-07-01), Mann et al.
patent: 4944298 (1990-07-01), Sholder
patent: 5199428 (1993-04-01), Obel et al.
patent: 5203326 (1993-04-01), Collins
patent: 5330507 (1994-07-01), Schwartz
patent: 5466254 (1995-11-01), Helland
patent: 5476483 (1995-12-01), Bornzin et al.
patent: 5522854 (1996-06-01), Ideker et al.
patent: 5578061 (1996-11-01), Stroetmann et al.
patent: 5700282 (1997-12-01), Zabara
patent: 5836976 (1998-11-01), Min et al.
patent: 6006134 (1999-12-01), Hill et al.
patent: 6134470 (2000-10-01), Hartlaub
patent: 6141590 (2000-10-01), Renirie et al.
patent: 6314323 (2001-11-01), Ekwall
patent: 2003/0181951 (2003-09-01), Cates
patent: 0547734 (1993-06-01), None
patent: 0547734 (1993-06-01), None
patent: 0547734 (1993-06-01), None
A 1449 filed in parent case, U.S. Appl. No. 10/420,998, filed Apr. 21, 2003 (copies of these not enclosed).
Shamsham, Fadi M.D. et al., “Essentials of the Diagnosis of Heart Failure,” American Family Physician (Mar. 1, 2000), vol. 61, No. 5, pp. 1319-1328.
Grassi, Guido M.D. et al., “Sympathetic Activation and Loss of Reflex Sympathetic Control in Mild Congestive Heart Failure,” American Heart Association, Inc., CIRCULATION (Dec. 1, 1995), vol. 92, No. 11, pp. 3206-3211.
Eisenhofer, Graeme PhD. et al., “Cardiac Sympathetic Nerve Function in Congestive Heart Failure,” American Heart Association, Inc., CIRCULATION (May 1, 1996), vol. 93, No. 9, pp. 1667-1676.
Cao, Ji-Min M.D. et al., “Relationship Between Regional Cardiac Hyperinnervation and Ventricular Arrhythmia,” CIRCULATION (Apr. 25, 2000), pp. 1960-1969.
Cohn, Jay N. M.D., “Preventing Congestive Heart Failure,” American Family Physician (Apr. 15, 1998), vol. 57, No. 8, pp. 1901-1904.
Frantz, Robert P. M.D., “Beta Blockade in Patients with Congestive Heart Failure,” Postgraduate Medicine (Sep. 1, 2000), vol. 108, No. 3, pp. 103-118.
Loh, Evan, “Overview : Old and New Controversies in the Treatment of Advanced Congestive Heart Failure,” Journal of Cardiac Failure, vol. 7, No. 2 (Suppl. 1) (2001).
Gomberg-Maitland, Mardi et al., “Treatment of Congestive Heart Failure,” American Medical Association, Arch Intern Med. (Feb. 12, 2001), pp. 342-352.
Mendelowitz, David, “Advances in Parasympathetic Control of Heart Rate and Cardiac Function,” News Physiol. Sci. (Aug. 1999), vol. 14, pp. 155-161.
Pauza, Dainius H. et al., “Morphology, Distribution, and Variability of the Epicardiac Neural Ganlionated Subplexes in the Human Heart,” The Anatomical Record, 259:353-382 (2000).
Mizeres, Nicholas James, “The Cardiac Plexus in Man,” The American Journal of Anatomy, vol. 112, No. 2 (Mar. 1963), , pp. 141-155.
Murakami, Masahiko M.D. et al., “Effects of Cardiac Sympathetic Nerve Stimulation on the Ventricular End-Systolic Pressure-Volume Relationship and Plasma Norepinephrine Dynamics in Dogs,” Japanese Circulation Journal, vol. 61 (Oct. 1997), pp. 864-871.
Du, Xiao-Jun et al., “Response to Cardiac Sympathetic Activation in Transgenic Mice Overexpressing B2-Adrenergic Receptor,” AM J Physiol Heart Circ Physiol (1996), pp. H630-H636.
Kawada, Toru et al., “Vagosympathetic Interactions in Ischemia-Induced Myocardial Norepinephrine and Acetylcholine Release,” AM J Physiol Heart Circ Physiol (2001), pp. H216-H221.
Levett, J.M. M.D. et al., “Cardiace Augmentation Can Be Maintained by Continuous Exposure of Intrinsic Cardiac Neurons to a B-Adrenergic Agonist or Angiotensin II,” Journal of Surgical Research 66, Article 0390, pp. 167-173 (1996).
Burger, Andrew J. M.D. et al., “Comparison of the Occurrence of Ventricular Arrhythmias in Patients with Acutely Decompensated Congestive Heart Failure Receiving Dobutamine Versus Nesiritide Therapy,” The American Journal of Cardiology, vol. 88 (Jul. 1, 2001), pp. 35-39.
Yuji Murakawa, MD, et al., “Effect of Cervical Vagal Nerve Stimulation on Defibrillation Energy,”Jpn Heart J(Jan. 2003), vol. 44, pp. 91-100.
Johnson Shevon
Pacesetter Inc.
Pezzuto Robert
LandOfFree
Parasympathetic nerve stimulation for ICD and/or ATP patients does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Parasympathetic nerve stimulation for ICD and/or ATP patients, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Parasympathetic nerve stimulation for ICD and/or ATP patients will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-3734512